Search Within

GDMT, Medicine

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (73)
  2. Meeting Abstract (53)
  3. Research Letter (1)
Groups
  1. Department of Medicine (127)
  2. GSK Faculty (127)
  3. Gynecology Disease Management Team (127)
  4. Human Oncology and Pathogenesis Program (127)
  5. Solid Tumor Oncology Division (123)
  6. Gynecologic Medicine Service (118)

More Groups

People
  1. Michael Berger (58)
  2. David Solit (49)
  3. Carol Aghajanian (40)
  4. Marc Ladanyi (40)
  5. Zsofia Stadler (30)
  6. Britta Weigelt (29)

More People

Years
  1. 2025 (3)
  2. 2024 (14)
  3. 2023 (18)
  4. 2022 (21)
  5. 2021 (14)
  6. 2020 (20)

More Years

Publications
  1. Journal of Clinical Oncology (29)
  2. Gynecologic Oncology (10)
  3. JCO Precision Oncology (9)
  4. Clinical Cancer Research (8)
  5. Modern Pathology (8)
  6. Annals of Oncology (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (39)
  2. American Association for Cancer Research (22)
  3. Elsevier Inc. (16)
  4. Nature Publishing Group (9)
  5. Nature Research (9)
  6. Oxford University Press (9)

More Publishers

Results (127)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Is next generation sequencing (NGS) ready for routine clinical practice in gliomas? Results of a prospective study utilizing the MSK-IMPACT assay
    Meeting Abstract

    Omuro, A. M. P.; Zehir, A.; Cheng, D. T.; Berger, M. F.; Hyman, D. M.; Solit, D. B.; Baselga, J.; Ladanyi, M.; Arcila, M. E.; Hameed, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Intestinal Blautia is associated with reduced death from graft-versus-host disease
    Journal Article

    Jenq, R. R.; Taur, Y.; Devlin, S. M.; Ponce, D. M.; Goldberg, J. D.; Ahr, K. F.; Littmann, E. R.; Ling, L.; Gobourne, A. C.; Miller, L. C.; more...
    Biology of Blood and Marrow Transplantation (2015)

    Fulltext@MSK | Save
  • Phase I study of oral BKM120 and oral olaparib for high-grade serous ovarian cancer (HGSC) or triple-negative breast cancer (TNBC)
    Meeting Abstract

    Matulonis, U.; Wulf, G. M.; Birrer, M. J.; Westin, S. N.; Quy, P.; Bell-Mcguinn, K. M.; Lasonde, B.; Whalen, C.; Aghajanian, C.; Solit, D. B.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancer
    Journal Article

    Meisel, J. L.; Hyman, D. M.; Garg, K.; Zhou, Q.; Dao, F.; Bisogna, M.; Gao, J.; Schultz, N. D.; Grisham, R. N.; Phillips, M.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • BRAF Mutation is associated with early stage disease and improved outcome in patients with low-grade serous ovarian cancer
    Journal Article

    Grisham, R. N.; Iyer, G.; Garg, K.; DeLair, D.; Hyman, D. M.; Zhou, Q.; Iasonos, A.; Berger, M. F.; Dao, F.; Spriggs, D. R.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • A comprehensive analysis of BRAF and KRAS mutation status in low-grade serous (LGS) and serous borderline (SB) ovarian cancer (OC)
    Meeting Abstract

    Grisham, R. N.; Garg, K.; Zhou, Q.; Iasonos, A.; Berger, M. F.; Dao, F.; Hyman, D. M.; Levine, D. A.; Solit, D. B.; Aghajanian, C.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Genomic complexity and AKT dependence in serous ovarian cancer
    Journal Article

    Hanrahan, A. J.; Schultz, N.; Westfal, M. L.; Sakr, R. A.; Giri, D. D.; Scarperi, S.; Janakiraman, M.; Olvera, N.; Stevens, E. V.; She, Q. B.; more...
    Cancer Discovery (2012)

    Fulltext@MSK | Save